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PURPOSE: To compare two techniques for eliciting
and clarifying patient values for decision making
about colorectal cancer (CRC) screening: choice-
based conjoint analysis and a rating and ranking
task.
METHODS: Using our decision lab registry and uni-
versity e-mail lists, we recruited average risk adults
ages 48–75 for a written, mailed survey. Eligible
participants were given basic information about CRC
screening and six attributes of CRC screening tests,
then randomized to complete either a choice-based
conjoint analysis with 16 discrete choice tasks or a
rating and ranking task. The main outcome was the
most important attribute, as determined from conjoint
analysis or participant ranking. Conjoint analysis-
based most important attribute was determined from
individual patient-level utilities generated using mul-
tinomial logistic regression and hierarchical Bayesian
modeling.
RESULTS: Of the 114 eligible participants, 104
completed and returned questionnaires. Mean age
was 57 (range 48–73), 70% were female, 88% were
white, 71% were college graduates, and 62% were
up to date with CRC screening. Ability to reduce
CRC incidence and mortality was the most frequent
most important attribute for both the conjoint
analysis (56% of respondents) and rating/ranking
(76% of respondents) groups, and these proportions
differed significantly between groups (absolute dif-
ference 20%, 95% CI 3%, 37%, p =0.03). There were
no significant differences between groups in propor-
tion with clear values (p=0.352), intent to be
screened (p=0.226) or unlabelled test preference
(p=0.521)
CONCLUSIONS: Choice-based conjoint analysis pro-
duced somewhat different patterns of attribute impor-
tance than a rating and ranking task, but had little
effect on other outcomes.
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BACKGROUND
Cancer screening decision can be complex, and decision aids
have been developed to assist patients and providers in these
decisions.1–4 Consensus recommendations for high-quality deci-
sion aid design include the need to elicit, clarify, and incorporate
patient values and preferences5 but the best method for doing so
is not clear.6,7 Potential options include implicit techniques, in
which patients receive information about different aspects of the
decision and are able to consider their potential value on their
own (or with a prompt to “consider which factors are most
important to you”), and explicit techniques (e.g. rating, ranking,
discrete choice methods including conjoint analysis) in which
patients are asked specifically to compare the relative importance
of several potentially relevant characteristics of a decision. The
decision about which technique to use should ideally be guided
by information about efficacy and feasibility.
Conjoint analysis and discrete choice experiments (DCE) are
stated preference techniques developed in the fields of econom-
ics, marketing, and psychology.8 They offer many potential
advantages for values elicitation and clarification and have been
employed widely in transportation and environmental decision-
making but have only recently been used commonly in health.
Conjoint analysis and DCE are based on the theory that
decision options can be described by sets of attributes, each
made up of different levels.8,9
The relative value that patients attach to the different
attributes can be estimated by constructing a series of
hypothetical options made up of these attributes at differ-
ent levels and asking patients to rate, rank, or (in the case
of choice-based conjoint analysis and discrete choice
experiments) make choices between a set of hypothetical
options. These values can then be applied to real decision
options to help patients and providers consider how their
values might be reflected in actual decisions (e.g. which
screening strategy to adopt), or they can be used to design
new decision options, such as a new screening test.
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Few previous studies have compared different techniques
for values elicitation and clarification.10–12 We sought to
compare, in a randomized trial, two explicit techniques for
values clarification, choice-based conjoint analysis and a
rating and ranking task, for decision making about colorectal
cancer (CRC) screening. We chose to study CRC screening,
because it requires consideration of several different potential
screening strategies, each with different advantages and
disadvantages that may be viewed differently by patients
based on their personal values and preferences. We hypoth-
esized that the conjoint analysis technique, which asks
subjects to consider explicit trade-offs, might lead to greater
engagement in the process of considering one’s values, and
produce a more diverse pattern of most important attributes.
Our main outcome of interest was the “most important
attribute” determined from the conjoint analysis or the
participant ranking task. Key secondary outcomes included
the most important attribute based on a single post-task




Participants were recruited from the UNC Decision Support
Lab participant registry (made up of volunteers who have
agreed to be available for decision making studies) and
through the University of North Carolina’s mass informational
electronic mail system for faculty, staff, and students. Partici-
pants recruited from the registry were contacted via their
preferred contact method, either e-mail or postal mail. Those
responding to the mass e-mail recruitment were contacted via
email.
Potential participants were ages 48–75 years with no
personal or immediate family (mother, father, sister, or broth-
er) history of colon cancer, polyps, or inflammatory bowel
disease. We did not exclude participants based on a history of
recent CRC screening, but instead asked everyone to respond
as if their doctor currently wanted them to decide about a CRC
screening test. Those who were eligible and agreed to partic-
ipate were randomized to intervention (conjoint task) or control
(rating and ranking task). Participants were then mailed a
packet of written material. The packet contained a pre-task
survey (identical across all groups), either the conjoint or
rating and ranking task, and a post-task survey (identical
across all groups). All participants who completed and
returned the surveys received a $25 gift card.
Development of Attributes
We developed a set of six key CRC screening test attributes
from literature reviews and our previous research: ability to
reduce CRC incidence and mortality, discomfort from
screening, nature of the screening test, frequency of
screening, risk of major complications over 10 years, and
out-of -pocket costs over 10 years.13,14 These attributes
were used for both the choice-based conjoint analysis tasks
and rating and ranking tasks.
Development of Attribute Levels
We then developed a plausible range of levels for each attribute to
be used in the conjoint analysis task. (See Appendix Table 1-
available online) The range of the levels for each attribute was
designed to cover the range of plausible values for each attribute,
based on previous studies.15,16 We described the risk reduction
for CRC incidence and mortality in relative terms, but also
provided both groups with lifetime absolute risk levels in the
absence of screening. We described risk of complications and out
of pocket costs over 10 years to allowmore accurate comparisons
of different programs of screening. We chose to combine test
location, preparation time, and time spent having the test in a
single attribute, as these characteristics are clustered together
for actual test options. Levels for this attribute were based on our
prior research using patient time diaries.17,18
Development of the Values Elicitation
and Clarification Tasks
Conjoint Task. To create the conjoint analysis scenarios, we
used a fractional factorial design implemented with Sawtooth
Software (www.sawtoothsoftware.com) to generate a balanced
and efficient choice-based set of choice tasks from our chosen
attributes and levels. Each choice task involved a comparison of
two hypothetical options (“1” and “2”) made up of the six
attributes with different combinations of levels. For each task,
the participant was asked to choose between options 1 and 2 or
state that they had no preference between the two. (See Appendix
2—available online)
Based on previous research suggesting that participants may
fatigue when the number of choice scenarios is too high19, we
chose to use a 15 scenario design, which increased feasibility
while still maintaining a high level of design efficiency (d-
efficiency 93.4). We also included a 16th scenario with a clear
dominant option to check whether respondents were attending
carefully to the choice tasks rather than answering randomly.
Rating and Ranking Test. To create the rating and ranking task,
we used the same attributes as for the choice-based conjoint
task. The rating exercise asked participants to rate, on a Likert
scale of 1–6, the importance of each attribute (1 = not important;
6 = very important). The ranking task then asked the respondent
to rank the three most important of the six attributes.
To control for ordering bias for both the rating and ranking
and conjoint analysis tasks, we randomized all participants to
one of five questionnaire versions that differed in terms of the
ordering of the attributes participants viewed.
Study Process
Prior to answering the pre-task survey questions, participants
were presented with written instructions and general informa-
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tion about colon cancer and colon cancer screening. Partici-
pants were instructed to imagine that their doctor has asked
them to make a decision about colon cancer screening. They
then completed the pre-task survey. After the pre-task survey,
participants received additional written information about
CRC and CRC screening and an explanation of the six
attributes of CRC screening tests. (See Appendix 3, available
online)
Measures
Surveys were the same for each group. The pre-task survey
included demographic and colon cancer risk perception ques-
tions. The post-task survey included a single question asses-
sing the most important attribute for each participant; a single
question on screening test preference, in which respondents
selected from a set of four unlabeled screening tests (designed
to simulate fecal occult blood testing, sigmoidoscopy, colono-
scopy, or a radiological test such as CT colonography) or the
option of no screening; the values clarity sub-scale of the
Decision Conflict Scale (three questions addressing clarity
about how benefits and adverse effects matter to the individ-
ual, scored on 0–100 scale, with clear values defined as a score
less than 25);20 and intent to be screened, measured on a five-
point Likert scale.
Analyses
To calculate each participant’s most important attribute for
those who completed the choice-based conjoint analysis task,
we used the hierarchical Bayesian (HB) analytic tool from
Sawtooth Software. Using HB allows one to estimate individual
level values for the attribute importance values and the part-
worth utilities (i.e. a quantitative assessment of the appeal of
attribute levels) when using a choice-based format. Hierarchi-
cal Bayesian analysis generates an algorithm that essentially
compares each individual’s responses to the different choice
tasks to the overall sample’s responses. This estimation is
done using a multinomial logit model and applying the
algorithm repeatedly until it stabilizes (or converges). The
multinomial logit model estimates the probability of a specific
scenario being chosen as a reflection of the total utility for the
chosen scenario (based on the sample response) relative to the
total utility for all scenarios including the chosen one.21–23
Main Outcome. Our main outcome was the most important
attribute based on the conjoint analysis importance score and
ranking task results. For those in the rating and ranking
group, we considered each participant’s most highly ranked
attribute to be the most important attribute. For those in the
conjoint analysis group, we considered the attribute with the
highest importance score to be the most important attribute.
We compared, across groups, the proportions of participants
reporting an attribute as being most important (using
Pearson’s chi-square tests.)
Secondary Outcomes. We used chi-square tests to compare
the most important attribute as expressed on the single
question from the post-task survey. We then examined
agreement, using the kappa statistic, between each
participant’s most important attribute determined from the
values clarification task and their most important attribute
based on the single question response.
We also used chi-square tests to compare the proportion of
participants with clear values in each group.20 T-tests were
used to compare intent to be screened between groups. Finally,
we performed stratified analyses to determine if there were
differences in our results based on prior history of screening.
Analyses were conducted in STATA 9.0.
RESULTS
Participant Characteristics
The study flow diagram is shown in the ase check if correct.
Figure 1 and the characteristics of the 104 participants are
shown in Table 1. There were few differences between groups
in baseline characteristics, although the rating and ranking
group had a somewhat higher proportion of participants who
were up to date with screening than the conjoint analysis
group (67% vs. 54%).
Responses
Among the 50 conjoint analysis respondents, two (4%) had one
missing response each; 49 (98%) answered the dominant
scenario correctly; and nine (18%) had at least one scenario
Figure 1. Study flow.
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in which they chose no preference. Of all 748 scenarios in
which a response was recorded, 59 (7.8%) were “no prefer-
ence”, with two respondents having six or more “no preference”
responses. There were no missing responses to the rating and
ranking task.
Most Important Attributes
For the conjoint analysis group, the most important attributes
based on the calculated importance scores generated from the
16 choice tasks are shown in Table 2. The importance scores
for each participant in the conjoint group are shown in
Appendix 4—available online. The ability to reduce CRC
incidence and mortality was the attribute most frequently
determined (based on importance score) to be most important.
The results of the rating and ranking tasks are shown in
Table 3. Ratings were generally high (mean score > 4.0) for all
attributes. The ability to reduce CRC incidence and mortality
was again most frequently ranked as the most important
attribute. Only four of the 54 participants (7.4%) in this group
had clearly discordant ratings and rankings for most impor-
tant attribute (i.e. their highest ranked attribute was rated
lower than one or more other attributes).
The proportion of participants for whom reduction in CRC
incidence and mortality was most important was lower for the
conjoint analysis group (56%) than for the rating and ranking
group (76%). (difference 20% points, 95% CI 3, 37; p<0.001)
Adjusting for baseline differences in being up to date with
screening had little effect on the odds of choosing ability to
reduce CRC as most important attribute (unadjusted OR 2.5
(95% CI 1.1,5.7); adjusted OR 2.1 (95% CI 0.9,5.1)).
Results for the most important attribute as assessed by a
single question on the post-task questionnaire are shown in
Table 4. Ability to reduce CRC incidence and mortality was the
most frequent response in each group, and there were no
differences between groups in the proportion of participants
choosing that attribute as most important (56% vs. 61%, p=
0.597). Agreement between the most important attributes from
the values clarification task and most important attribute from
the single question on the post-task survey was moderate, and
slightly higher for the rating and ranking group (simple
agreement 65%, kappa 0.32) than for the conjoint analysis
group (simple agreement 52%, kappa 0.26), suggesting the
conjoint analysis may provide distinct information compared
with a single question.
Other Outcomes
There were no statistically significant differences between
groups in the proportion of participants having clear values
(based on a values clarity sub-scale score < 25): 76% for those
completing the conjoint analysis task and 83% for those
completing the ranking and rating task (p=0.63). Intent to be
screened was also similar between groups (4.2 for conjoint
group vs. 4.4 for rating and ranking group, p=0.22). Finally,
unlabeled test preferences were also similar between groups:
the set of attributes corresponding to screening colonoscopy
every 10 years was most frequently chosen in each group, but
the sets of attributes corresponding to FOBT and radiological
testing were also popular; only 3% of respondents answered
that they would choose “no testing.” (See Table 5)
DISCUSSION
We found that a choice-based conjoint analysis task produced
somewhat different patterns of attribute importance compared
with a rating and ranking task, but had little effect on other
key outcomes, including values clarity, intent to be screened,
and unlabelled screening test preference. This finding suggests
that a choice-based method, which requires consideration of
trade-offs between attributes, may provide distinct information
about how patients value different test features compared with
other simpler explicit methods like rating and ranking. How-
ever, completing the more involved conjoint analysis choice
tasks does not appear to have large effects on more distal and
global outcomes such as clarity about the decision, prefer-
ences about decision options, or intent to engage in health
behaviors. Clinically, our findings suggest that the ability to
reduce CRC incidence and mortality is the most important
attribute for a majority, but not all, participants. The impor-
tance of other attributes differed across our sample, suggesting
that providing information about each domain may be impor-
tant in counseling patients.
Few prior studies have compared different techniques for
values elicitation and clarification. O’Connor and colleagues
found no difference in values clarity or treatment preference
when comparing an implicit technique (provision of a balance
sheet) versus an explicit rating task in 201 women deciding
about hormone replacement therapy.10 In a trial of 137





Mean age in years (SD) 57.5 (5.7) 56.9 (7.1)
% female 68 72
% Caucasian 88 87
% college graduate or higher 74 68
% Income < $45,000 20 25
% up to date with any
type of screening
54 67
% up to date with colonoscopy 50 56

















56% 20% 10% 86%
Discomfort 2% 0% 2% 4%
Nature of test 18% 24% 32% 74%
Frequency 20% 27% 16% 63%
Complications 4% 0% 26% 30%
Out of pocket
costs
0% 29% 14% 43%
48 Pignone et al.: Conjoint Analysis in Colorectal Cancer Screening JGIM
participants considering a hypothetical heart disease preven-
tion scenario, we found that rating and ranking did not
produce differences in decisional conflict or intent to adopt
risk-reducing interventions compared with an implicit ap-
proach, but the two approaches did produce somewhat
different patterns of preferred labeled treatments.11 In another
study of 113 volunteers, we found that a conjoint analysis task
produced different patterns of preferences and treatment
choices than direct elicitation for a hypothetical heart disease
prevention scenario.12 Finally, Sheridan and colleagues found
no difference in decisional conflict when they compared a
prostate cancer screening decision aid without values clarifi-
cation versus the decision aid with one of two different values
clarification exercises (social matching and ranking /
rating). However, participants differed in their intent to be
screened, suggesting the method of values clarification may
be important.24
Although we are not aware of other published studies that
have compared different methods of values elicitation for CRC
screening, several have used explicit techniques to assess key
decisional attributes.13,25–28 (Details of these studies are
provided in Appendix 5-available online) Most studies have
found test accuracy (ability to detect cancer and polyps) to be
the most common most important attribute, but the order of
importance of other attributes has varied considerably across
studies.
Our study has several limitations. First, we enrolled a
relatively small sample population drawn from our decision
laboratory registry and university e-mail lists. The small
sample size limits our ability to detect small differences
between groups with precision. Moreover, the size of a
clinically meaningful effect for values clarification has not
been well-defined, and will require further research to help
design future studies. Second, our sample was not represen-
tative of the full population of adults ages 48–74, being more
highly educated and predominantly female, although the
proportion who were up to date with screening was similar
(slightly lower) than the general population of North Caroli-
nians of the same age range.29
Third, we studied a hypothetical scenario; real-world screen-
ing decisions (and evaluation of actual test completion) may
produce different results. Fourth, a more extensive or different
set of attributesmayhave produceddifferent patterns of attribute
importance. Similarly, choosing different levels may have pro-
duced different results for the conjoint task. Fifth, our use of a
mail-based survey made it infeasible to examine the effect of
giving conjoint results back to patients to determine the effect of
such feedback. Sixth, information about absolute risk was
provided in the introductory materials only; whether using
absolute risks within the conjoint task would have affected
results further is unclear.
We only provided limited information about CRC screen-
ing to both groups, and we did not provide the specific
range of levels for each attribute to those in the rating and
ranking group. Providing such information might have
changed attribute preferences. However, our choice of
information in the rating and ranking group was meant to
provide a parsimonious approach to values elicitation, as
might be performed in clinical encounters. Future studies
might compare the conjoint analysis approach versus a rating
and ranking task in which the range of levels was included in the
attribute descriptions or against another technique like “max
diff” scaling.28 We did not assess knowledge, so we cannot
determine the extent to which the expressed values are repre-
sentative of informed consumers. Finally, we measured our
Table 3. Rating and Ranking of Attributes (n=54)
Attribute Rating* Ranking
Mean rating (SD) Most important 2nd most important 3rd most important % in top 3
Ability to reduce colorectal
cancer incidence and mortality
5.9 (0.4) 76% 11% 9% 96%
Discomfort 4.1 (1.5) 9% 17% 17% 43%
Nature of test 4.1 (1.6) 4% 7% 13% 24%
Frequency 4.7 (1.4) 2% 22% 15% 39%
Complications 4.7 (1.6) 6% 30% 30% 66%
Out of pocket costs 4.3 (1.4) 4% 13% 17% 34%
*Rated on 1–6 scale (1 = not at all important, 6 = very important)









Nature of test 8% 6%
Frequency 12% 6%
Risk of major complications 2% 4%
Out of pocket costs 10% 17%

















No test 4% 2%
FOBT = fecal occult blood test
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outcomes only after the values elicitation tasks. Measuring
changes from pre-task to post-task might have provided more
sensitive assessment of changes.
In conclusion, we found that attribute importance scores
derived from a choice-based conjoint analysis produced some-
what different patterns of attribute importance than those
derived from rating and ranking tasks for the decision about
which strategy to use for CRC screening. Whether the differences
in attribute values observed here are meaningful enough to
warrant the additional time and effort required to complete the
conjoint analysis / discrete choice tasks, compared with rating
and ranking, or even implicit values clarification techniques,
remains unclear and will require additional research.
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